← Eichor
Condition: Recurrent Respiratory Tract Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Respiratory Tract Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Y
Phase 2 · 2 location(s) · Min-Tze LIONG · NCT07297966ML-Based ABPA Recurrence Prediction and Clinical Utility
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT07714863Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06168032Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia
Phase N/A · 1 location(s) · Centre Hospitalier Intercommunal Aix-Pertuis · NCT06607055Prevention With Ismigen of RTIs in Kids
Phase 4 · 10 location(s) · Lallemand Pharma AG · NCT07578012SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06435403Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Phase N/A · 1 location(s) · Charles University, Czech Republic · NCT06201494Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Zopa Retreatment and Vector Shedding in Adults With RRP
Phase 4 · 3 location(s) · Precigen, Inc · NCT06538480Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In th
Phase 4 · 10 location(s) · Laboratorio Farmaceutico SIT srl · NCT06736288Evaluation of Patients With Immune Function Abnormalities
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00128973Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT06860542Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis
NA · 6 location(s) · The Archer-Daniels-Midland Company · NCT06480604The Effect of Systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Vs Intraoperative Infiltration of Steroids in Tonsi
NA · 1 location(s) · Ain Shams University · NCT07035314Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
NA · 1 location(s) · Tampere University Hospital · NCT04645511SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds
NA · 1 location(s) · Alaa Emara · NCT06543823Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT07611838Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor
Phase 2 · 15 location(s) · Genelux Corporation · NCT06463665
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.